Alpha Tau Medical (DRTS) Change in Account Payables (2021 - 2022)

Alpha Tau Medical (DRTS) posted quarterly Change in Account Payables of -$2.6 million for Q2 2022, down 200.23% on a QoQ basis from $2.6 million in Q1 2022.

Alpha Tau Medical (DRTS) Change in Account Payables (2021 - 2022) Analysis & Trends

Alpha Tau Medical (DRTS) has reported Change in Account Payables for 2 consecutive years, with -$2.6 million the latest figure, recorded in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -42.19 Mn
4 NuCana 279.75 Bn 279.75 Bn - -1.52 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 35.60 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 16.86 Mn
10 Alpha Tau Medical 1.19 Bn 1.11 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2022 -2.63 Mn
Jun 30, 2022 -2.63 Mn
Mar 31, 2022 2.63 Mn
Mar 31, 2022 2.63 Mn
Mar 31, 2021 72,000.00
Mar 31, 2021 72,000.00